Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited

Cadila Pharmaceuticals Limited

A Trailblazer, Committed to Address Health Challenges with Cutting-Edge Technologies: Cadila Pharmaceuticals

The Indian pharmaceutical industry has witnessed remarkable growth in recent years. Its market size is expected to reach around $65 billion by the end of 2024 and $130 billion by 2030.

With its commitment to addressing critical health challenges, Cadila Pharmaceuticals has flung its wings as one of India’s largest privately held pharmaceutical companies. It was established in 1951 and successfully evolved into a trusted name for high-quality and affordable healthcare solutions. Cadila Pharmaceuticals’ key offerings include a diverse portfolio of products spanning various therapeutic segments, such as cardiovascular, respiratory, gastrointestinal, anti-infective, and oncology.

Perpetually dedicated to quality and innovation, Cadila Pharmaceuticals has achieved remarkable growth throughout its six-decade journey as a care-focused, research-driven company.

Under the hegemony of Chairman and Managing Director Dr Rajiv I. Modi, Cadila Pharmaceuticals introduced several groundbreaking drugs, including Calcirol, the world’s first vitamin D injection; Polycap, a multi-drug combination for cardiovascular disease; and ThRabis, the world’s first threedose rabies vaccine. The company’s distinctive organizational structure underscores its unwavering commitment to quality research and development.

Addressing Medical Needs: Dr. Rajiv’s Inspiring Journey

Seventy-three years ago, Mr Indravadan A. Modi, Dr. Rajiv’s father, laid the foundation of Cadila Pharmaceuticals with a vision to make healthcare accessible to all. Dr Rajiv’s father served as an inspiration to him; his dedication and commitment to quality and innovation served as guiding principles for him. He joined Cadila Pharmaceuticals to carry on his father’s legacy, drive forward the company’s mission of improving lives, and leverage scientific advancements to address unmet medical needs.

Read Full Article Here: https://businessconnectindia.in/cadila-pharmaceuticals-limited/

Must Read:

要查看或添加评论,请登录

社区洞察

其他会员也浏览了